Pharmacokinetic Interactions of Ribavirin and Abacavir in Hepatitis-C Mono-infected Male Subjects Who Previously Failed Ribavirin-based Treatment.
Phase of Trial: Phase I
Latest Information Update: 02 May 2017
At a glance
- Drugs Abacavir (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- 06 Mar 2013 Status changed from recruiting to completed.
- 06 Mar 2013 Results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
- 22 Jun 2011 Planned end date changed from 1 Dec 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History